📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
12
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
37%
📉 Score Deterioration
40%
• Score rose 28 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($750M, 177% of market cap)
• Active ATM program with $750M remaining capacity
🔄 Reverse Split
30%
• 50-day avg $1.97 approaching $1 threshold
💹 Market Data
Market Cap$423.73M
Shares Outstanding130.78M
Float120.60M
Cash$585.00M
Debt$4.45B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 18.4% shares (2025Q4 vs prior)
255 institutional holders · 130.62M shares
#1
VANGUARD GROUP INC
11.38M shares
#2
BlackRock, Inc.
9.77M shares
#3
GOLDMAN SACHS GROUP INC
9.29M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest29.31M
Days to Cover2.7
% of Float24.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Feb 12, 2026
3
FORM3
Apr 08, 2026
3
FORM3
Apr 08, 2026
4
INSIDER TRANSACTION
Mar 13, 2026
4
INSIDER TRANSACTION
Mar 13, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XRX
📊 XRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XRX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.